07:00 , Mar 11, 2013 |  BC Week In Review  |  Clinical News

Cu-64-TP3805 diagnostic data

Researchers at Thomas Jefferson University reported data from 13 breast cancer patients showing that Positron Emission Mammography (PEM) imaging using Cu-64-TP3805 had 100% sensitivity and 100% specificity for distinguishing malignant from benign breast cancer lesions....
08:00 , Nov 9, 2009 |  BC Week In Review  |  Clinical News

NuView preclinical data

In a mouse model of breast cancer, positron emission tomography (PET) imaging using NVB-64 identified all 8 malignant tumors and no benign tumors. The control imaging agent F-18-fluorodeoxyglucose (F-18-FDG) identified 4 malignant tumors, missed 4...